Kestra Advisory Services’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,177
| Closed | -$265K | – | 2777 |
|
|
2024
Q4 | $265K | Buy |
5,177
+70
| +1% | +$3.58K | ﹤0.01% | 2313 |
|
|
2024
Q3 | $261K | Buy |
5,107
+24
| +0.5% | +$1.23K | ﹤0.01% | 2178 |
|
|
2024
Q2 | $228K | Buy |
+5,083
| New | +$228K | ﹤0.01% | 2306 |
|
|
2024
Q1 | – | Sell |
-7,400
| Closed | -$263K | – | 2471 |
|
|
2023
Q4 | $263K | Sell |
7,400
-31
| -0.4% | -$1.1K | ﹤0.01% | 1931 |
|
|
2023
Q3 | $221K | Buy |
+7,431
| New | +$221K | ﹤0.01% | 1879 |
|